3651 results for «477»

Filter By

3651 results

In-stent restenosis: exploring novel solution for an old problem

22 May 2026 – From EuroPCR 2026

This session explores innovative approaches to treating in-stent restenosis (ISR) with a focus on drug-coated balloons (DCB) and sirolimus or paclitaxel-eluting balloon catheters. It includes clinical outcomes from IVUS-guided procedures, cutting balloon angioplasty, comparisons between DCB and DES, and emerging machine learning tools to predict target-lesion...

In-stent restenosis: exploring novel solution for an old problem

All you need to know - Intracoronary imaging for vulnerable plaque

22 May 2026 – From EuroPCR 2026

This session provides a comprehensive overview of vulnerable plaque pathophysiology and the role of intracoronary imaging in its identification. It assesses treatment options, including the potential role of preventative PCI and intensive medical therapy, to guide clinical decision-making in managing plaque vulnerability.

All you need to know - Intracoronary imaging for vulnerable plaque

Is there a rule for DCB in ACS setting?

22 May 2026 – From EuroPCR 2026

This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and...

How should I treat my CTO? Adapting to local conditions

22 May 2026 – From EuroPCR 2026

This session delves into managing chronic total occlusions (CTO) under resource-limited conditions, highlighting the essential CTO toolbox and strategic procedural planning. It emphasizes that an antegrade-first approach, often with dual arterial access, can achieve high success in many CTO cases, illustrated through complex real-world cases from...

Taking on the tough stuff: TAVI in complex anatomies

21 May 2026 – From EuroPCR 2026

Focused on the challenges of transcatheter aortic valve implantation (TAVI) in complex anatomies, this session addresses optimal strategies for treating bicuspid aortic valve stenosis, managing small annuli and low coronary ostia, and approaches to degenerated surgical valves including bioprosthetic fracture techniques. Case-based discussions elucidate practical solutions...

Taking on the tough stuff: TAVI in complex anatomies

Hybrid percutaneous revascularisation: combining DES and DCB for optimal results

21 May 2026 – From EuroPCR 2026

This session delves into hybrid percutaneous revascularisation techniques that combine drug-eluting stents (DES) and drug-coated balloons (DCB) to achieve optimal clinical results. It highlights the clinical and anatomical scenarios suited for hybrid PCI, provides a step-by-step procedural approach, and discusses the potential benefits of integrating these...

Hybrid percutaneous revascularisation: combining DES and DCB for optimal results

INOCA in patients with coronary artery disease

21 May 2026 – From EuroPCR 2026

This session focuses on ischaemia with non-obstructive coronary arteries (INOCA) in patients with coronary artery disease. It raises awareness of common clinical presentations, emphasizes accurate diagnosis through functional coronary testing, and discusses how tailored treatment strategies can improve patient outcomes in this frequently under-recognized condition.

INOCA in patients with coronary artery disease

Overcoming challenging anatomy in calcified lesion PCI

22 May 2026 – From EuroPCR 2026

This session focuses on overcoming the challenges posed by complex anatomical variations in calcified lesion PCI. Experts present advanced techniques and hybrid solutions for difficult bifurcation angles, aorto-ostial lesions, and other complex scenarios, emphasizing both innovative and simplified approaches to achieve procedural success.

Calcium in the coronary arteries - What could go wrong?

22 May 2026 – From EuroPCR 2026

This session delves into the complexities of treating calcified coronary artery lesions, highlighting strategic selection of PCI approaches, anticipation of potential complications, and agile adaptation of techniques to manage these challenges effectively. Featuring real-world cases from Ireland and the United Kingdom, it provides critical learnings on...

New insights into pharmacological treatment for STEMI

21 May 2026 – From EuroPCR 2026

This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...

Challenges for TAVI in bicuspid

22 May 2026 – From EuroPCR 2026

This session addresses the unique challenges encountered during transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves. It covers procedural nuances for type 0 bicuspid valves, risks associated with anomalous coronary anatomy, and complex anatomical considerations such as large annulus and tortuous aorta, culminating...

Spontaneous coronary artery dissection management with intracoronary imaging

22 May 2026 – From EuroPCR 2026

Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

21 May 2026 – From EuroPCR 2026

This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

Beyond coronary arteries: SVG and peripheral interventions

22 May 2026 – From EuroPCR 2026

This session expands focus beyond coronary arteries to cover interventions in saphenous vein grafts (SVG) and peripheral arteries. It reviews long-term clinical outcomes of SVG PCI, real-world data from coronary artery bypass graft interventions, and advances in ultrasound-guided treatments of peripheral artery lesions, including predictors of...

Shock: enhancing our pathways of care

21 May 2026 – From EuroPCR 2026

This session explores advancements in the management pathways for patients experiencing cardiogenic shock, particularly those complicating STEMI. It discusses patient characteristics, timing of PCI procedures, updated SCAI shock staging, representation in clinical trials, and angiographic findings in shockable out-of-hospital cardiac arrest cases, aiming to enhance clinical...

Diversity in coronary artery disease treatment

22 May 2026 – From EuroPCR 2026

Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...

Complex coronary artery intervention: how DCB can help us

21 May 2026 – From EuroPCR 2026

This session delves into the role of Drug-Coated Balloons (DCB) in managing complex coronary artery interventions. It covers DCB-based PCI approaches in challenging lesions, compares clinical outcomes between Paclitaxel-coated balloon-only PCI and other strategies, and evaluates the effectiveness of DCB versus Drug-Eluting Stents (DES) in de...

Complication management in CTO PCI - Part 2

22 May 2026 – From EuroPCR 2026

This session focuses on managing complications during chronic total occlusion (CTO) PCI procedures. It presents challenging cases including artery perforations, donor vessel-related procedural difficulties, and intramural hematoma rescue guided by intravascular ultrasound (IVUS). Strategies to address in-stent CTO and the unpredictable nature of CTO PCI complications...

Nightmare scenarios in the cathlab

21 May 2026 – From EuroPCR 2026

This session presents challenging and unexpected scenarios encountered in the catheterisation laboratory, highlighting critical complications such as stent-induced coronary dissections, acute arterial occlusions, and procedural catastrophes. Real-life cases illustrate emergency management strategies, including rescue techniques for vascular complications and early recognition of acute syndromes, underscoring the...

Left main PCI-complex procedures

22 May 2026 – From EuroPCR 2026

This session covers complex left main coronary artery PCI procedures that challenge standard algorithms. It includes tackling chronic total occlusions of the left main, managing spontaneous coronary artery dissection in patients on ECMO, handling stent dislodgement, and addressing complex trifurcation lesions, providing comprehensive insights into advanced...

Didn’t find what you were looking for?